MAPK3 and neuroblastoma: In conclusion, the present study demonstrates that, by activating epigenetic mechanisms involving derepression of RUNX3 expression and stimulating signaling pathways mediated by ERK1/2 and JNK, VPA upregulates TrkC in human neuroblastoma cells (Figure 9).